AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$392M |
| 2 |
Qualcomm
QCOM
|
+$262M |
| 3 |
Microsoft
MSFT
|
+$260M |
| 4 |
Illumina
ILMN
|
+$259M |
| 5 |
International Flavors & Fragrances
IFF
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$341M |
| 2 |
Biogen
BIIB
|
+$295M |
| 3 |
Apple
AAPL
|
+$289M |
| 4 |
Booking.com
BKNG
|
+$207M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 15.41% |
| 3 | Financials | 15.33% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDC
1751
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.91M | ﹤0.01% |
82,449
-114,886
| -58% | -$4.32M |
|
1752
Nutanix
NTNX
$15.4B
| $2.91M | ﹤0.01% |
92,950
+640
| +0.7% | +$18.9K |
|
1753
DNOW Inc
DNOW
$2.59B
| $2.9M | ﹤0.01% |
258,323
-150
| -0.1% | -$1.67K |
|
|
PGNX
1754
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.9M | ﹤0.01% |
570,002
+450,500
| +377% | +$2.38M |
|
|
KAMN
1755
DELISTED
Kaman Corp
KAMN
| $2.89M | ﹤0.01% |
43,824
+200
| +0.5% | +$12.5K |
|
1756
Xencor
XNCR
$1.47B
| $2.88M | ﹤0.01% |
83,875
+300
| +0.4% | +$11K |
|
|
CPE
1757
DELISTED
Callon Petroleum Company
CPE
| $2.88M | ﹤0.01% |
59,528
+22,850
| +62% | +$945K |
|
|
CUB
1758
DELISTED
Cubic Corporation
CUB
| $2.87M | ﹤0.01% |
45,150
+250
| +0.6% | +$16.9K |
|
1759
The RMR Group
RMR
$348M
| $2.87M | ﹤0.01% |
62,764
-1,200
| -2% | -$55.7K |
|
|
CBMB
1760
DELISTED
CBM Bancorp, Inc.
CBMB
| $2.86M | ﹤0.01% |
202,443
+9,364
| +5% | +$131K |
|
1761
Collegium Pharmaceutical
COLL
$1.15B
| $2.85M | ﹤0.01% |
138,510
| – | – |
|
|
PMBC
1762
DELISTED
Pacific Mercantile Bancorp
PMBC
| $2.85M | ﹤0.01% |
+350,335
| New | +$2.56M |
|
|
MINI
1763
DELISTED
Mobile Mini Inc
MINI
| $2.84M | ﹤0.01% |
75,014
-40
| -0.1% | -$1.51K |
|
|
TRTN
1764
DELISTED
Triton International Limited
TRTN
| $2.84M | ﹤0.01% |
70,700
| – | – |
|
1765
Insmed
INSM
$22.7B
| $2.83M | ﹤0.01% |
118,700
+11,800
| +11% | +$240K |
|
1766
iShares US Technology ETF
IYW
$23.3B
| $2.83M | ﹤0.01% |
+48,720
| New | +$2.65M |
|
|
HVBC
1767
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
| $2.83M | ﹤0.01% |
166,378
+31,691
| +24% | +$483K |
|
1768
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
| $2.83M | ﹤0.01% |
34,700
+16,780
| +94% | +$1.34M |
|
1769
8x8 Inc
EGHT
$262M
| $2.82M | ﹤0.01% |
154,206
+830
| +0.5% | +$16K |
|
|
STEL
1770
DELISTED
Stellar Bancorp
STEL
| $2.82M | ﹤0.01% |
90,608
+300
| +0.3% | +$8.8K |
|
1771
Medifast
MED
$110M
| $2.82M | ﹤0.01% |
25,718
-7,850
| -23% | -$760K |
|
1772
Federal Signal
FSS
$7.22B
| $2.81M | ﹤0.01% |
87,280
+1,050
| +1% | +$34.2K |
|
1773
Credit Acceptance
CACC
$5.78B
| $2.8M | ﹤0.01% |
6,325
-2,960
| -32% | -$1.3M |
|
1774
Novartis
NVS
$297B
| $2.8M | ﹤0.01% |
29,533
+428
| +1% | +$38.4K |
|
|
AYX
1775
DELISTED
Alteryx Inc
AYX
| $2.79M | ﹤0.01% |
27,923
+3,030
| +12% | +$308K |
|
Similar funds
AllianceBernstein's Q4 2019 Portfolio in Review
As of Q4 2019, AllianceBernstein held 3,209 positions worth $176B, up 9.6% from $161B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.6%. AllianceBernstein opened 57 new positions and exited 91, leaving the 3,209-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2019 buy was Tradeweb Markets: 1,191,306 shares worth $55.2M.
- AllianceBernstein added most to Nike in Q4 2019, an estimated $392M increase.
- AllianceBernstein's biggest Q4 2019 reduction was JPMorgan Chase, cutting an estimated $341M.
- AllianceBernstein fully exited Celgene Corp in Q4 2019, selling an estimated $194M.
- AllianceBernstein's ten largest holdings make up 19% of its $176B portfolio in Q4 2019.
- AllianceBernstein opened 57 new positions and closed 91 in Q4 2019.
- AllianceBernstein's portfolio value rose 9.6% quarter-over-quarter to $176B.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.